GLP-1 medications reduce that compulsive pull toward food without eliminating the pleasure of eating entirely
Moreover, we excluded patients and controls who suffered from neurodegenerative and neuroinflammatory disorders, such as chronic fatigue syndrome [54], Parkinsons or Alzheimers disease, multiple sclerosis, stroke, or systemic (auto)immune diseases such as diabetes mellitus, psoriasis, rheumatoid arthritis, inflammatory bowel disease and scleroderma, and liver and renal disease
Additionally, L-carnitine improves postprandial flow-mediated dilation, slightly increasing vascular function
They're delivering a specific dose calibrated to a specific carbohydrate load, a specific activity level, a specific stress response, and a blood glucose reading taken minutes before
People who prefer oral medications over injections have historically leaned toward phentermine